The European Medicines Agency’s (EMA) scientific guidelines on the clinical evaluation of medicines used in nervous-system disorders help medicine developers prepare marketing authorisation applications for human medicines.
If you have comments on a document which is open for consultation, use the form for submission of comments on scientific guidelines.
Please submit your comments to the following email address: firstname.lastname@example.org.
Points to consider
How useful is this page?
Average rating:Based on 0 ratings
Add your rating:
- See all ratings
0 ratings0 ratings0 ratings0 ratings0 ratings